摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Phenyl-1-(p-hydroxyphenyl)-cyclopentan | 36744-76-0

中文名称
——
中文别名
——
英文名称
1-Phenyl-1-(p-hydroxyphenyl)-cyclopentan
英文别名
1-(p-Hydroxyphenyl)-1-phenylcyclopentan;4-(1-Phenyl-cyclopentyl)-phenol;4-Hydroxy-1-(1-phenyl-cyclopentyl)-benzol;4-(1-Phenylcyclopentyl)phenol
1-Phenyl-1-(p-hydroxyphenyl)-cyclopentan化学式
CAS
36744-76-0
化学式
C17H18O
mdl
——
分子量
238.329
InChiKey
PNYGZLDEFPPDPC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    环戊酮 、 alkaline earth salt of/the/ methylsulfuric acid 在 磷酸三氟化硼 作用下, 生成 1-Phenyl-1-(p-hydroxyphenyl)-cyclopentan
    参考文献:
    名称:
    Zavgorodnii,S.V.; Kozlikovskii,Y.B., Journal of Organic Chemistry USSR (English Translation), 1972, vol. 8, p. 809 - 812
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
    申请人:GENENTECH INC
    公开号:WO2010080503A1
    公开(公告)日:2010-07-15
    In one aspect, the present invention provides for a compound of Formula I; in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.
    在一个方面,本发明提供了一种具有式I的化合物;其中变量X1a、X1b、X1c、X1d、Q、A、R1、B、L、E和下标m和n的含义如本文所述。在另一个方面,本发明提供了包括式I化合物的药物组合物,以及使用式I化合物治疗由Bcl-2抗凋亡蛋白(例如抗凋亡Bcl-xL蛋白)的表达或过度表达所特征的疾病和状况(例如癌症、血小板增多症等)的方法。
  • HETEROCYCLIC COMPOUNDS AND METHODS OF USE
    申请人:Baell Jonathan Bayldon
    公开号:US20100210622A1
    公开(公告)日:2010-08-19
    In one aspect, the present invention provides for a compound of Formula I in which the variable X 1a , X 1b , X 1c , X 1d , Q, A, R 1 , B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-x L proteins.
    在一个方面,本发明提供了一种式子为I的化合物,其中变量X1a,X1b,X1c,X1d,Q,A,R1,B,L,E和下标m和n的含义如此处所述。在另一个方面,本发明提供了包含式子I化合物的制药组合物,以及使用式子I化合物治疗由Bcl-2抗凋亡蛋白(例如抗凋亡Bcl-xL蛋白)的表达或过表达所特征的疾病和病状(例如癌症,血小板增多症等)的方法。
  • Method of preparing oligomeric polyol compositions
    申请人:Presidium USA, Inc
    公开号:US11066512B2
    公开(公告)日:2021-07-20
    There is provided an oligomeric polyol composition having (a) an oligomeric network containing residues of at least one polyhydroxylated aromatic compound and residues of at least one polyol having at least three hydroxyl groups; and (b) a plurality of peripheral groups having one or more pendant hydroxyl groups bound to the oligomeric network by a plurality of linking units. The residues of the polyol may optionally contain one or more oxygen ether groups, one or more amino ether groups, or both of one or more oxygen ether groups and one or more amino ether groups. Reaction of the oligomeric polyols with isocyanate monomers affords a new class of polyurethanes having superior heat and water resistance. The new polyurethanes exhibit lower peak exotherms, typically less than 250° F. during in-mold polymerization. Articles prepared from polyurethanes incorporating such oligomeric polyol compositions exhibit flexural strengths and moduli in excess of 10,000 psi and 400,000 psi respectively, and outstanding green strength.
    本发明提供了一种低聚多元醇组合物,该组合物具有:(a) 低聚网络,其中包含至少一种多羟基芳香族化合物的残留物和至少一种具有至少三个羟基的多元醇的残留物;以及(b) 多个外围基团,这些外围基团具有一个或多个通过多个连接单元与低聚网络结合的垂羟基。多元醇的残基可选择含有一个或多个氧醚基团、一个或多个基醚基团,或同时含有一个或多个氧醚基团和一个或多个基醚基团。低聚多元醇与异氰酸酯单体反应可产生一类新型聚酯,具有优异的耐热性和耐性。这种新型聚酯的放热峰值较低,模内聚合时通常低于 250°F。用含有此类低聚多元醇组合物的聚酯制备的物品,其抗弯强度和模量分别超过 10,000 psi 和 400,000 psi,并且具有出色的绿色强度。
  • Polyurethanes prepared from oligomeric polyol compositions and polyisocyanates
    申请人:Presidium USA, Inc
    公开号:US11072679B2
    公开(公告)日:2021-07-27
    There is provided an oligomeric polyol composition having (a) an oligomeric network containing residues of at least one polyhydroxylated aromatic compound and residues of at least one polyol having at least three hydroxyl groups; and (b) a plurality of peripheral groups having one or more pendant hydroxyl groups bound to the oligomeric network by a plurality of linking units. The residues of the polyol may optionally contain one or more oxygen ether groups, one or more amino ether groups, or both of one or more oxygen ether groups and one or more amino ether groups. Reaction of the oligomeric polyols with isocyanate monomers affords a new class of polyurethanes having superior heat and water resistance. The new polyurethanes exhibit lower peak exotherms, typically less than 250° F. during in-mold polymerization. Articles prepared from polyurethanes incorporating such oligomeric polyol compositions exhibit flexural strengths and moduli in excess of 10,000 psi and 400,000 psi respectively, and outstanding green strength.
    本发明提供了一种低聚多元醇组合物,该组合物具有:(a) 低聚网络,其中包含至少一种多羟基芳香族化合物的残留物和至少一种具有至少三个羟基的多元醇的残留物;以及(b) 多个外围基团,这些外围基团具有一个或多个通过多个连接单元与低聚网络结合的垂羟基。多元醇的残基可选择含有一个或多个氧醚基团、一个或多个基醚基团,或同时含有一个或多个氧醚基团和一个或多个基醚基团。低聚多元醇与异氰酸酯单体反应可产生一类新型聚酯,具有优异的耐热性和耐性。这种新型聚酯的放热峰值较低,模内聚合时通常低于 250°F。用含有此类低聚多元醇组合物的聚酯制备的物品,其抗弯强度和模量分别超过 10,000 psi 和 400,000 psi,并且具有出色的绿色强度。
  • Substituted cycloalkyl phenols and method of making same
    申请人:DOW CHEMICAL CO
    公开号:US02262249A1
    公开(公告)日:1941-11-11
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫